Adenosine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00640 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obsolete bundle branch block | KG + DL |
| 2 | catecholaminergic polymorphic ventricular tachycardia | KG + DL |
| 3 | periodic paralysis with transient compartment-like syndrome | KG + DL |
| 4 | incessant infant ventricular tachycardia | KG + DL |
| 5 | arrhythmogenic right ventricular cardiomyopathy | KG + DL |
| 6 | primary hereditary glaucoma | KG + DL |
| 7 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 8 | open-angle glaucoma | KG + DL |
| 9 | specific developmental disorder | KG + DL |
| 10 | angle-closure glaucoma | KG + DL |
| 11 | faciodigitogenital syndrome | KG + DL |
| 12 | closed-angle glaucoma | KG + DL |
| 13 | attention deficit-hyperactivity disorder | KG + DL |
| 14 | aqueous misdirection | KG + DL |
| 15 | traumatic glaucoma | KG + DL |
| 16 | neovascular glaucoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.